Roger Badía

1.7k total citations
51 papers, 1.3k citations indexed

About

Roger Badía is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Roger Badía has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Virology, 22 papers in Infectious Diseases and 15 papers in Immunology. Recurrent topics in Roger Badía's work include HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (20 papers) and Immune Cell Function and Interaction (11 papers). Roger Badía is often cited by papers focused on HIV Research and Treatment (32 papers), HIV/AIDS drug development and treatment (20 papers) and Immune Cell Function and Interaction (11 papers). Roger Badía collaborates with scholars based in Spain, Italy and United States. Roger Badía's co-authors include José A. Esté, Ester Ballana, Bonaventura Clotet, Eva Riveira‐Muñoz, P. Martı́nez, Eduardo Pauls, Alba Ruiz, Maria Pujantell, Ramón Martí and Javier Torres‐Torronteras and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Roger Badía

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Badía Spain 22 509 432 386 378 232 51 1.3k
Aldar S. Bourinbaiar United States 20 435 0.9× 376 0.9× 452 1.2× 573 1.5× 327 1.4× 72 1.6k
Ilona Hauber Germany 26 404 0.8× 1.0k 2.3× 247 0.6× 609 1.6× 235 1.0× 51 2.0k
Andrew Low Australia 17 531 1.0× 466 1.1× 392 1.0× 238 0.6× 145 0.6× 28 1.1k
Eleftherios Michailidis United States 24 531 1.0× 691 1.6× 1.2k 3.0× 252 0.7× 726 3.1× 46 2.1k
Carol Lackman-Smith United States 14 330 0.6× 278 0.6× 307 0.8× 83 0.2× 149 0.6× 22 791
Sonsoles Sánchez‐Palomino Spain 17 511 1.0× 419 1.0× 374 1.0× 233 0.6× 136 0.6× 45 1.1k
Yossef Raviv United States 18 391 0.8× 501 1.2× 335 0.9× 173 0.5× 163 0.7× 27 1.2k
John‐Erik Stig Hansen Denmark 18 471 0.9× 341 0.8× 276 0.7× 344 0.9× 142 0.6× 51 974
Dmitri N. Ivanov United States 19 469 0.9× 545 1.3× 254 0.7× 274 0.7× 154 0.7× 29 964
Michael W. Cho United States 19 1.1k 2.1× 421 1.0× 815 2.1× 715 1.9× 355 1.5× 36 1.8k

Countries citing papers authored by Roger Badía

Since Specialization
Citations

This map shows the geographic impact of Roger Badía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Badía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Badía more than expected).

Fields of papers citing papers by Roger Badía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Badía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Badía. The network helps show where Roger Badía may publish in the future.

Co-authorship network of co-authors of Roger Badía

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Badía. A scholar is included among the top collaborators of Roger Badía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Badía. Roger Badía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García-Vidal, Edurne, Eva Riveira‐Muñoz, Elisabet García, et al.. (2024). Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response. International Journal of Molecular Sciences. 25(10). 5318–5318. 1 indexed citations
2.
Ezeonwumelu, Ifeanyi Jude, Edurne García-Vidal, Eva Riveira‐Muñoz, et al.. (2022). Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection. International Journal of Molecular Sciences. 23(23). 15000–15000. 1 indexed citations
3.
Ezeonwumelu, Ifeanyi Jude, Edurne García-Vidal, Eudald Felip, et al.. (2022). IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation. Frontiers in Immunology. 13. 1001068–1001068. 5 indexed citations
4.
Nalli, Marianna, Domiziana Masci, Antonio Coluccia, et al.. (2020). New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains. European Journal of Medicinal Chemistry. 208. 112696–112696. 12 indexed citations
5.
Forgione, Mariantonietta, Alessia Lucidi, Alexandros Patsilinakos, et al.. (2018). Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3H)-ones. Journal of Medicinal Chemistry. 62(2). 604–621. 17 indexed citations
6.
Badía, Roger, Ester Ballana, Edurne García-Vidal, et al.. (2018). CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nature Communications. 9(1). 2739–2739. 57 indexed citations
7.
Badía, Roger, Ester Ballana, José A. Esté, & Eva Riveira‐Muñoz. (2017). Antiviral treatment strategies based on gene silencing and genome editing. Current Opinion in Virology. 24. 46–54. 12 indexed citations
8.
Pujantell, Maria, Eva Riveira‐Muñoz, Roger Badía, et al.. (2017). RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages. Scientific Reports. 7(1). 13339–13339. 49 indexed citations
9.
Badía, Roger, Maria Pujantell, Eva Riveira‐Muñoz, et al.. (2016). The G1/S Specific Cyclin D2 Is a Regulator of HIV-1 Restriction in Non-proliferating Cells. PLoS Pathogens. 12(8). e1005829–e1005829. 34 indexed citations
10.
Badía, Roger, Eva Riveira‐Muñoz, Maria Pujantell, et al.. (2015). Inhibition of herpes simplex virus type 1 by the CDK6 inhibitor PD-0332991 (palbociclib) through the control of SAMHD1. Journal of Antimicrobial Chemotherapy. 71(2). 387–394. 36 indexed citations
11.
Badía, Roger, Judith Grau-Expósito, Eva Riveira‐Muñoz, et al.. (2015). The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent. Antiviral Research. 123. 62–69. 18 indexed citations
12.
Ruiz, Alba, Eduardo Pauls, Roger Badía, et al.. (2014). Characterization of the Influence of Mediator Complex in HIV-1 Transcription. Journal of Biological Chemistry. 289(40). 27665–27676. 25 indexed citations
13.
Famiglini, Valeria, Giuseppe La Regina, Antonio Coluccia, et al.. (2014). New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 80. 101–111. 23 indexed citations
14.
15.
Riveira‐Muñoz, Eva, Eduardo Pauls, Marc Permanyer, et al.. (2014). Increased expression of SAMHD1 in a subset of HIV-1 elite controllers. Journal of Antimicrobial Chemotherapy. 69(11). 3057–3060. 23 indexed citations
16.
Permanyer, Marc, Eduardo Pauls, Roger Badía, José A. Esté, & Ester Ballana. (2013). The Cortical Actin Determines Different Susceptibility of Naïve and Memory CD4+ T Cells to HIV-1 Cell-to-Cell Transmission and Infection. PLoS ONE. 8(11). e79221–e79221. 7 indexed citations
17.
18.
Badía, Roger, R. Lizardo, Raquel Martín-Venegas, et al.. (2012). β-Galactomannan and Saccharomyces cerevisiae var. boulardii Modulate the Immune Response against Salmonella enterica Serovar Typhimurium in Porcine Intestinal Epithelial and Dendritic Cells. Clinical and Vaccine Immunology. 19(3). 368–376. 41 indexed citations
19.
Permanyer, Marc, Ester Ballana, Roger Badía, et al.. (2012). Trans-infection but Not Infection from within Endosomal Compartments after Cell-to-cell HIV-1 Transfer to CD4+ T Cells. Journal of Biological Chemistry. 287(38). 32017–32026. 12 indexed citations
20.
Ballana, Ester, Beatriz Mothe, Eva Ramírez de Arellano, et al.. (2012). Differential prevalence of the HLA-C −35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals. Immunobiology. 217(9). 889–894. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026